Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Healthon Inc. dba Healthon
WARNING LETTER
•Healthon Inc. dba Healthon•August 1, 2025

Healthon Inc. dba Healthon – FDA Warning Letter, Aug 1, 2025

Record Details

Healthon Inc., doing business as Healthon, received a warning letter from the FDA on September 9, 2025, following a review of its website in August 2025. The agency determined that the company’s marketing for compounded semaglutide and tirzepatide products—often used for weight loss—contained false or misleading information. Specifically, Healthon claimed its products used the "same active ingredient" as popular FDA-approved medications like Ozempic, Wegovy, Mounjaro, and Zepbound. It also incorrectly stated that its ingredients were FDA-approved. Because compounded drugs do not undergo the same rigorous approval process as brand-name medications, these claims misrepresent the products" regulatory status. Under the Federal Food, Drug, and Cosmetic Act, these misrepresentations classify the products as misbranded. The FDA has instructed Healthon to immediately cease using this misleading language and to investigate all potential violations within its operations. The company must provide a written response within 15 working days detailing the specific steps taken to correct the issues and prevent them from happening again. Failure to comply with these requirements could result in legal action, including product seizures or court-ordered injunctions.

Company
Healthon Inc. dba Healthon
Inspection date
August 1, 2025
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Rasoul Montazeri
  • George Tidmarsh (Director)
View Company Profile

ID · 9dae4e37-cf25-43b6-a4a5-b3676a8c474b

Violation Codes10
21 U.S.C. 331(c)21 U.S.C. 352(a)FD&C Act 201(p)FD&C Act 502(bb)21 U.S.C. 352(bb)FD&C Act 201(g)(1)FD&C Act 502(a)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)FD&C Act 301(a)

Full citation text and observation details available on the Dashboard.

Other documents for Healthon Inc. dba Healthon
  • WARNING_LETTER - 2025-08-31August 31, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Healthon Inc. dba Healthon
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.